INT49195

From wiki-pain
Jump to: navigation, search
Context Info
Confidence 0.34
First Reported 1995
Last Reported 2010
Negated 0
Speculated 0
Reported most in Abstract
Documents 6
Total Number 6
Disease Relevance 4.23
Pain Relevance 0.15

This is a graph with borders and nodes. Maybe there is an Imagemap used so the nodes may be linking to some Pages.

signal transduction (CSF3R) extracellular region (CSF3R) cell adhesion (CSF3R)
plasma membrane (CSF3R)
Anatomy Link Frequency
granulocyte 5
CSF3R (Homo sapiens)
Pain Link Frequency Relevance Heat
Pain 13 89.08 High High
cva 2 40.76 Quite Low
headache 2 25.00 Low Low
imagery 7 5.00 Very Low Very Low Very Low
antagonist 6 5.00 Very Low Very Low Very Low
positron emission tomography 5 5.00 Very Low Very Low Very Low
palliative 2 5.00 Very Low Very Low Very Low
cytokine 2 5.00 Very Low Very Low Very Low
Analgesic 1 5.00 Very Low Very Low Very Low
Inflammation 1 5.00 Very Low Very Low Very Low
Disease Link Frequency Relevance Heat
Syndrome 7 99.98 Very High Very High Very High
Neutropenia 5 99.80 Very High Very High Very High
Leukocytosis 30 99.30 Very High Very High Very High
Lymphatic System Cancer 8 98.80 Very High Very High Very High
Metastasis 12 98.70 Very High Very High Very High
Recurrence 7 98.40 Very High Very High Very High
Multiple Organ Failure 2 98.24 Very High Very High Very High
Chondrosarcoma 37 93.80 High High
Leukemia 2 91.60 High High
Osteogenic Sarcomas 4 91.52 High High

Sentences Mentioned In

Key: Protein Mutation Event Anatomy Negation Speculation Pain term Disease term
Sweet's syndrome associated with granulocyte colony-stimulating factor.
granulocyte colony-stimulating factor Binding (associated) of in granulocyte associated with syndrome
1) Confidence 0.34 Published 1998 Journal Eur J Dermatol Section Title Doc Link 9854164 Disease Relevance 0.99 Pain Relevance 0.09
COP-BLAM regimen combined with granulocyte colony-stimulating factor and high-grade non-Hodgkin's lymphoma.
granulocyte colony-stimulating factor Binding (combined) of in granulocyte associated with lymphatic system cancer
2) Confidence 0.29 Published 1995 Journal Eur. J. Haematol. Section Title Doc Link 7543059 Disease Relevance 0.58 Pain Relevance 0.06
The clinical efficacy of COP-BLAM chemotherapy combined with human recombinant granulocyte colony-stimulating factor (G-CSF) was evaluated in 104 previously untreated patients with non-Hodgkin's lymphoma (NHL).
granulocyte colony-stimulating factor Binding (combined) of in granulocyte associated with lymphatic system cancer
3) Confidence 0.25 Published 1995 Journal Eur. J. Haematol. Section Abstract Doc Link 7543059 Disease Relevance 0.27 Pain Relevance 0
After hemipelvectomy, when local recurrence and metastasis were identified, leukocytosis appeared and an elevated level of serum granulocyte-colony-stimulating factor (G-CSF) was also recognized.
serum granulocyte-colony-stimulating factor Binding (recognized) of in granulocyte associated with leukocytosis, metastasis and recurrence
4) Confidence 0.24 Published 2006 Journal World J Surg Oncol Section Abstract Doc Link PMC1526734 Disease Relevance 1.62 Pain Relevance 0
Ro 25-8315 is produced by conjugation of rhG-CSF mutant with polyethylene glycol (PEG).
rhG-CSF mutant Binding (conjugation) of
5) Confidence 0.24 Published 2001 Journal Am. J. Hematol. Section Abstract Doc Link 11279634 Disease Relevance 0 Pain Relevance 0
Granulocyte colony-stimulating factor (G-CSF) was used to minimize the neutropenia associated with this regimen.
Granulocyte colony-stimulating factor Binding (minimize) of in Granulocyte associated with neutropenia
6) Confidence 0.14 Published 2010 Journal OncoTargets and therapy Section Body Doc Link PMC2895780 Disease Relevance 0.77 Pain Relevance 0

General Comments

This test has worked.

Personal tools
Namespaces

Variants
Actions
Navigation
Toolbox